Lilly(Eli) & Company
NYSE: LLY
$834.96
+$21.63 (+2.7%)
Real Time Data Delayed 15 Min.
LLY Articles
Biotech investing is a thrill-a-minute ride. Biotech stocks can take investors soaring to new heights and fabulous wealth opportunities or send them into the pits of despair. The drug discovery...
Published:
The release of OpenAI‘s ChatGPT chatbot in November 2022 unleashed a frenzy of investor interest in artificial intelligence that propelled Nvidia (NASDAQ:NVDA) to the forefront of the industry. The...
Published:
Unless you have been living under the rock, you’d have heard of Nvidia’s (NASDAQ: NVDA) success story. All investors want a bite of this big business and those who missed out are now trying to...
Published:
Capitalizing on the popularity of weight-loss drugs like Wegovy and Zepbound, Hims & Hers Health (NYSE:HIMS) has exploited a loophole in Food & Drug Administration regulations to bring to...
Published:
The surge in interest investors have displayed for companies delivering weight loss drugs has been impressive. Indeed, the growth various weight loss drugs have seen is notable, with GLP-1 agonists...
Published:
Remember when a stock becoming valued at $1 trillion was a big thing? The first company to do so was Apple (NASDAQ:AAPL) back in 2018. Now there are a half dozen trillion-dollar stocks. And while a...
Published:
The July Consumer Price Index (CPI) appears to progress towards the Federal Reserve’s 2% inflation target rate. Consumer prices have started cooling after rising a modest 2.9% in the 12 months...
Published:
Holding a promising future due to recent success in the obesity drug market, Eli Lilly (NYSE:LLY) appears to be bound for continued gains. An impressive move higher in LLY stock, with the company’s...
Published:
Long-term stocks, or those that are meant to be held for over a year, let investors ignore daily market fluctuations. Known as “sleep-at-night” stocks, they remain reliable in the face of...
Published:
Eli Lilly (NYSE: LLY) stock has been a winner for investors of late, owing largely to strong consumer demand for obesity drugs. Shares have ballooned by nearly 60% year-to-date, while investors have...
Published:
Wall Street expectations for where Eli Lilly stock is headed this year vary considerably, but some analysts still have faith.
Published:
ETFs have become an exceptionally popular choice for investors seeking diversification and exposure to large market segments. Thematic ETFs, like the iShares S&P 500 Value ETF (NYSE: IVE),...
Published:
Many investors choose to invest in ETFs or mutual funds, which provide immediate diversification. These versatile “baskets” of securities offer a convenient way to gain exposure to many different...
Published:
ETFs and mutual funds can both be powerful tools for investors seeking diversification. Both of these investment vehicles hold baskets of securities. When you purchase them, you’re also purchasing...
Published:
SCHD and VOO are two very popular ETFs for investors looking to diversify quickly. Like all ETFs, these two investment vehicles hold a “bucket” of stocks. However, the stocks they hold are very...
Published: